The Effect of Adrenergic and Ganglionic Blockers upon the L-Dopa-Stimulated Release of Glucagon in the Rat

To help characterize the L-dopa-mediated release of glucagon, rats were given either L-dopa or dopamine (10 mg/kg) intravenously; portal plasma levels of insulin, glucagon and glucose were measured in the presence and absence of adrenergic and ganglionic blockers. The alpha-adrenergic blocker (phent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: George,David T, Bailey,Paul T
Format: Report
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator George,David T
Bailey,Paul T
description To help characterize the L-dopa-mediated release of glucagon, rats were given either L-dopa or dopamine (10 mg/kg) intravenously; portal plasma levels of insulin, glucagon and glucose were measured in the presence and absence of adrenergic and ganglionic blockers. The alpha-adrenergic blocker (phentolamine) suppressed the glucagon and glucose response to L-dopa and increased plasma insulin levels. Beta-adrenergic blockade with propranolol ameliorated the L-dopa-mediated glucagon and glucose responses but had no effect on plasma insulin levels. Ganglionic blockade with pentolinium tartrate was ineffective and did not alter any of the L-dopa-mediated responses of glucagon, insulin or glucose. These data indicate that L-dopa and dopamine probably act via the sympathetic nervous system through known pathways enchancing the release of glucagon. Furthermore they substantiate the fact that the adrenergic nervous system is involved in the regulation of the endocrine pancreas. (Author)
format Report
fullrecord <record><control><sourceid>dtic_1RU</sourceid><recordid>TN_cdi_dtic_stinet_ADA034518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ADA034518</sourcerecordid><originalsourceid>FETCH-dtic_stinet_ADA0345183</originalsourceid><addsrcrecordid>eNqFjDEOwjAQBNNQIOAHFPeBSKCARGtICAVVSB-d7LMxHHYUX_5PEPRUq9HO7jx7tHeCylrSAtGCMgMFGpzXgMFAjcGxj2HCI0f9pCHB2McAMq2ueRl7zG_iXyOjkIGGmDDR56jmUaObTP-VG5RlNrPIiVa_XGTrc9WeLrkRr7skPpB0qlSbYrffHoo_9RsKRzw_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>The Effect of Adrenergic and Ganglionic Blockers upon the L-Dopa-Stimulated Release of Glucagon in the Rat</title><source>DTIC Technical Reports</source><creator>George,David T ; Bailey,Paul T</creator><creatorcontrib>George,David T ; Bailey,Paul T ; ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FREDERICK MD</creatorcontrib><description>To help characterize the L-dopa-mediated release of glucagon, rats were given either L-dopa or dopamine (10 mg/kg) intravenously; portal plasma levels of insulin, glucagon and glucose were measured in the presence and absence of adrenergic and ganglionic blockers. The alpha-adrenergic blocker (phentolamine) suppressed the glucagon and glucose response to L-dopa and increased plasma insulin levels. Beta-adrenergic blockade with propranolol ameliorated the L-dopa-mediated glucagon and glucose responses but had no effect on plasma insulin levels. Ganglionic blockade with pentolinium tartrate was ineffective and did not alter any of the L-dopa-mediated responses of glucagon, insulin or glucose. These data indicate that L-dopa and dopamine probably act via the sympathetic nervous system through known pathways enchancing the release of glucagon. Furthermore they substantiate the fact that the adrenergic nervous system is involved in the regulation of the endocrine pancreas. (Author)</description><language>eng</language><subject>AS841 ; AUTONOMIC AGENTS ; Biochemistry ; DOPAMINE ; GLUCAGON ; GLUCOSE ; INSULIN ; L-Dopa ; PANCREAS ; PE62776A ; Pentolinum tartrate ; Pharmacology ; Phentolamine ; Propanolol ; RATS ; SYMPATHETIC NERVOUS SYSTEM ; SYMPATHOLYTIC AGENTS ; WU022</subject><creationdate>1976</creationdate><rights>APPROVED FOR PUBLIC RELEASE</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,776,881,27546,27547</link.rule.ids><linktorsrc>$$Uhttps://apps.dtic.mil/sti/citations/ADA034518$$EView_record_in_DTIC$$FView_record_in_$$GDTIC$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>George,David T</creatorcontrib><creatorcontrib>Bailey,Paul T</creatorcontrib><creatorcontrib>ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FREDERICK MD</creatorcontrib><title>The Effect of Adrenergic and Ganglionic Blockers upon the L-Dopa-Stimulated Release of Glucagon in the Rat</title><description>To help characterize the L-dopa-mediated release of glucagon, rats were given either L-dopa or dopamine (10 mg/kg) intravenously; portal plasma levels of insulin, glucagon and glucose were measured in the presence and absence of adrenergic and ganglionic blockers. The alpha-adrenergic blocker (phentolamine) suppressed the glucagon and glucose response to L-dopa and increased plasma insulin levels. Beta-adrenergic blockade with propranolol ameliorated the L-dopa-mediated glucagon and glucose responses but had no effect on plasma insulin levels. Ganglionic blockade with pentolinium tartrate was ineffective and did not alter any of the L-dopa-mediated responses of glucagon, insulin or glucose. These data indicate that L-dopa and dopamine probably act via the sympathetic nervous system through known pathways enchancing the release of glucagon. Furthermore they substantiate the fact that the adrenergic nervous system is involved in the regulation of the endocrine pancreas. (Author)</description><subject>AS841</subject><subject>AUTONOMIC AGENTS</subject><subject>Biochemistry</subject><subject>DOPAMINE</subject><subject>GLUCAGON</subject><subject>GLUCOSE</subject><subject>INSULIN</subject><subject>L-Dopa</subject><subject>PANCREAS</subject><subject>PE62776A</subject><subject>Pentolinum tartrate</subject><subject>Pharmacology</subject><subject>Phentolamine</subject><subject>Propanolol</subject><subject>RATS</subject><subject>SYMPATHETIC NERVOUS SYSTEM</subject><subject>SYMPATHOLYTIC AGENTS</subject><subject>WU022</subject><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>1976</creationdate><recordtype>report</recordtype><sourceid>1RU</sourceid><recordid>eNqFjDEOwjAQBNNQIOAHFPeBSKCARGtICAVVSB-d7LMxHHYUX_5PEPRUq9HO7jx7tHeCylrSAtGCMgMFGpzXgMFAjcGxj2HCI0f9pCHB2McAMq2ueRl7zG_iXyOjkIGGmDDR56jmUaObTP-VG5RlNrPIiVa_XGTrc9WeLrkRr7skPpB0qlSbYrffHoo_9RsKRzw_</recordid><startdate>19760930</startdate><enddate>19760930</enddate><creator>George,David T</creator><creator>Bailey,Paul T</creator><scope>1RU</scope><scope>BHM</scope></search><sort><creationdate>19760930</creationdate><title>The Effect of Adrenergic and Ganglionic Blockers upon the L-Dopa-Stimulated Release of Glucagon in the Rat</title><author>George,David T ; Bailey,Paul T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-dtic_stinet_ADA0345183</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>1976</creationdate><topic>AS841</topic><topic>AUTONOMIC AGENTS</topic><topic>Biochemistry</topic><topic>DOPAMINE</topic><topic>GLUCAGON</topic><topic>GLUCOSE</topic><topic>INSULIN</topic><topic>L-Dopa</topic><topic>PANCREAS</topic><topic>PE62776A</topic><topic>Pentolinum tartrate</topic><topic>Pharmacology</topic><topic>Phentolamine</topic><topic>Propanolol</topic><topic>RATS</topic><topic>SYMPATHETIC NERVOUS SYSTEM</topic><topic>SYMPATHOLYTIC AGENTS</topic><topic>WU022</topic><toplevel>online_resources</toplevel><creatorcontrib>George,David T</creatorcontrib><creatorcontrib>Bailey,Paul T</creatorcontrib><creatorcontrib>ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FREDERICK MD</creatorcontrib><collection>DTIC Technical Reports</collection><collection>DTIC STINET</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>George,David T</au><au>Bailey,Paul T</au><aucorp>ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FREDERICK MD</aucorp><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><btitle>The Effect of Adrenergic and Ganglionic Blockers upon the L-Dopa-Stimulated Release of Glucagon in the Rat</btitle><date>1976-09-30</date><risdate>1976</risdate><abstract>To help characterize the L-dopa-mediated release of glucagon, rats were given either L-dopa or dopamine (10 mg/kg) intravenously; portal plasma levels of insulin, glucagon and glucose were measured in the presence and absence of adrenergic and ganglionic blockers. The alpha-adrenergic blocker (phentolamine) suppressed the glucagon and glucose response to L-dopa and increased plasma insulin levels. Beta-adrenergic blockade with propranolol ameliorated the L-dopa-mediated glucagon and glucose responses but had no effect on plasma insulin levels. Ganglionic blockade with pentolinium tartrate was ineffective and did not alter any of the L-dopa-mediated responses of glucagon, insulin or glucose. These data indicate that L-dopa and dopamine probably act via the sympathetic nervous system through known pathways enchancing the release of glucagon. Furthermore they substantiate the fact that the adrenergic nervous system is involved in the regulation of the endocrine pancreas. (Author)</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_dtic_stinet_ADA034518
source DTIC Technical Reports
subjects AS841
AUTONOMIC AGENTS
Biochemistry
DOPAMINE
GLUCAGON
GLUCOSE
INSULIN
L-Dopa
PANCREAS
PE62776A
Pentolinum tartrate
Pharmacology
Phentolamine
Propanolol
RATS
SYMPATHETIC NERVOUS SYSTEM
SYMPATHOLYTIC AGENTS
WU022
title The Effect of Adrenergic and Ganglionic Blockers upon the L-Dopa-Stimulated Release of Glucagon in the Rat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A03%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-dtic_1RU&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.btitle=The%20Effect%20of%20Adrenergic%20and%20Ganglionic%20Blockers%20upon%20the%20L-Dopa-Stimulated%20Release%20of%20Glucagon%20in%20the%20Rat&rft.au=George,David%20T&rft.aucorp=ARMY%20MEDICAL%20RESEARCH%20INST%20OF%20INFECTIOUS%20DISEASES%20FREDERICK%20MD&rft.date=1976-09-30&rft_id=info:doi/&rft_dat=%3Cdtic_1RU%3EADA034518%3C/dtic_1RU%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true